Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Process for preparing tenofovir

A process and adenine technology, applied in the field of drug synthesis, can solve problems such as unsuitability for industrial production, production cost environmental protection defects, harsh dissociation conditions, etc., and achieve the effects of simple operation, low cost, and mild reaction conditions

Active Publication Date: 2014-06-18
SHANGHAI DESANO CHEM PHARMA
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] ①In the reaction to generate intermediate 2, when the magnesium salt mixture is converted to tenofovir, the magnesium salt mixture must be separated from the system after forced analysis with ethyl acetate, because the magnesium salt mixture is easy to absorb moisture and absorb The product has high operational requirements and is very cumbersome in actual processing;
[0010] ②Intermediate 2 must use harsh dissociation conditions due to dissociation of two ethyl groups;
[0011] ③ In terms of cost, due to the use of a large excess of trimethylsilane and sodium bromide, there are serious defects in both production cost and environmental protection
[0014] Although this process overcomes some defects of the above-mentioned paper route, because it uses a strong base such as sodium hydroxide to reflux at 120°C for 22 hours in the preparation of intermediate 1, the reaction conditions are severe and time-consuming, which is difficult in large-scale production. control
[0015] In summary, it can be seen that the preparation technology of tenofovir in the prior art has defects and deficiencies that are not suitable for industrialized production, and this area needs to study a simple method for preparing high-purity tenofovir suitable for industrialization. craft

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for preparing tenofovir
  • Process for preparing tenofovir
  • Process for preparing tenofovir

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038]

[0039] Dissolve adenine (17.4g, 0.13mol), potassium carbonate (21.5g, 0.15mol), R-propylene carbonate (15.8g, 0.15mol) in 50mL N,N-dimethylformamide, heat to 90~ 125°C, keep warm at 90-125°C for 3-6 hours; cool down to room temperature, add magnesium isopropoxide (15.7g, 0.14mol) under argon protection, heat up to 30-45°C, keep warm for 0.5-1 hour ; Add dimethyl p-toluenesulfonyloxymethylphosphonate (44.1g, 0.15mol) dropwise, and keep warm at 30-45°C to continue the reaction for 4-6 hours; the system is lowered to room temperature, and the reaction system is concentrated under reduced pressure to get viscous Intermediate 2 of the oily substance; add 124g of concentrated hydrochloric acid to the prepared intermediate 2, heat up to 90-110°C, and keep warm for 3-6 hours; cool down to room temperature, continue to react at room temperature for 1-2 hours, and filter with suction , the filter cake was washed twice with 150mL 5wt% dilute hydrochloric acid aqueous solution...

Embodiment 2

[0041]

[0042] Dissolve adenine (17.4g, 0.13mol), sodium carbonate (15.9g, 0.15mol), R-propylene carbonate (15.8g, 0.15mol) in 50mL of N-methylpyrrolidone, heat to 90-125°C, keep React at 90-125°C for 3-6 hours; cool down to room temperature, add magnesium tert-butoxide (23.8g, 0.14mol) under the protection of argon, heat up to 30-45°C, and keep warm for 0.5-1 hour; Diethyl toluenesulfonyloxymethylphosphonate (48.3g, 0.15mol), keep warm at 30-45°C and continue to react for 4-6 hours; lower the system to room temperature, concentrate the reaction system under reduced pressure to obtain a viscous oil in the middle Body 2; add 130g of concentrated sulfuric acid to the prepared intermediate 2, raise the temperature to 90-110°C, and keep it warm for 3-6 hours; cool down to room temperature, continue to react at room temperature for 1-2 hours, suction filter, and use the filter cake Wash twice with 150mL of 5wt% dilute sulfuric acid aqueous solution, adjust the pH of the filtrat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a process for preparing tenofovir. The method is characterized by comprising the steps: with adenine, (R)-propylene carbonate and p-toluenesulfonyloxy methyl phosphonic diester as raw materials, adopts a one-pot process to prepare an intermediate 2, and followed by hydrolyzing the intermediate 2 by an inorganic acid to obtain tenofovir, wherein the following reaction formula is shown in the description. With utilization of the process, the purpose that high-purity tenofovir is synthesized with utilization of cheap and easily available raw materials and with simple operation, mild reaction conditions, low cost and high yield is achieved; and the process has the advantages of energy saving and environmental protection, is suitable for large scale production, and has practical value in realization of industrial production of tenofovir.

Description

technical field [0001] The invention relates to a preparation process of tenofovir, which belongs to the technical field of drug synthesis. Background technique [0002] In 2009, the United Nations reported that the number of HIV-infected people in China had reached 740,000, and sexual transmission is becoming the main transmission route of AIDS in my country. This is a dangerous signal for the spread of AIDS from high-risk groups to the general population, and the prevention and control work is in a critical period. [0003] Tenofovir, as the first nucleotide analogue approved by the FDA for the treatment of HIV-1 infection, has also been recognized by the World Health Organization and recommended as a first-line antiviral drug. Due to the important impact of the drug, India accepted the request of Cipla, an Indian generic drug manufacturer, in September 2009 to refuse patent protection for Tenofovir to ensure that the drug can be more easily accepted by low-income countrie...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07F9/6561
Inventor 李金亮赵楠蔺如祥
Owner SHANGHAI DESANO CHEM PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products